Skip to main content

Table 2 Baseline severity of ABS signs and symptoms (per-protocol population, N = 42)

From: Eradication of common pathogens at days 2, 3 and 4 of moxifloxacin therapy in patients with acute bacterial sinusitis

Sign/symptom

Patients (%) with severity of:

 

None

Mild

Moderate

Severe

Purulent nasal drainage

1 (2.4)

2 (4.8)

17 (40.5)

22 (52.4)

Facial pain

3 (7.1)

4 (9.5)

19 (45.2)

16 (38.1)

Frontal headache

5 (11.9)

5 (11.9)

15 (35.7)

17 (40.5)

Throat clearing

6 (14.3)

10 (23.8)

20 (47.6)

6 (14.3)

Cough

9 (21.4)

9 (21.4)

12 (28.6)

12 (28.6)

Malar tenderness/pain

10 (23.8)

9 (21.4)

15 (35.7)

8 (19.0)

Halitosis

14 (33.3)

10 (23.8)

14 (33.3)

4 (9.5)